Innovator IBD 50 ETF Rating $26.67 -0.57 (-2.09%) As of 12:12 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartHoldingsOwnershipRatingsBuy This Stock Innovator IBD 50 ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.FFTY Aggregate RatingModerate Buy 2.69Holdings in FFTY have an aggregate rating of Moderate Buy based on 480 analyst ratings issued in the past year covering 44 companies (87.9% of the portfolio).FFTY Aggregate Price Target$26.67High Prediction$26.67Average Prediction$26.67Low Prediction$26.67Holdings in FFTY have an aggregate price target of $26.67 and a range of $26.67 to $26.67 covering 44 companies (87.9% of the portfolio).FFTY Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy9 Buy rating(s)Moderate Buy24 Moderate Buy rating(s)Hold11 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Innovator IBD 50 ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 44 FFTY Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings3.68%ACMRACM Research$23.08-6.2%3.0996 of 5 stars2.80$29.40 27.4%5Positive NewsGap Down3.65%ZLABZai Lab$36.06-3.3%2.1558 of 5 stars2.75$47.37 31.4%43.65%ROOTRoot$134.12-2.1%0.7735 of 5 stars2.56$88.33 -34.1%9Gap Up3.55%AXSMAxsome Therapeutics$116.29-1.9%4.745 of 5 stars3.00$167.64 44.2%15Short Interest ↓Gap Down3.49%HALOHalozyme Therapeutics$63.24-0.9%4.2656 of 5 stars2.60$62.78 -0.7%10News CoveragePositive News3.49%ATATAtour Lifestyle$28.42-0.1%3.1317 of 5 stars3.00$33.63 18.3%4Earnings ReportGap Down3.46%ALHCAlignment Healthcare$18.28-0.1%1.7446 of 5 stars2.67$14.83 -18.9%12Insider Trade3.41%ADMAADMA Biologics$19.29-4.8%2.4267 of 5 stars3.25$22.50 16.6%4Positive NewsGap Down3.19%TGTXTG Therapeutics$37.46-6.0%3.0146 of 5 stars2.83$40.67 8.6%6Positive NewsGap Down3.13%ARQTArcutis Biotherapeutics$15.19-3.4%2.6749 of 5 stars2.83$18.80 23.8%6Short Interest ↓Positive NewsGap Down3.07%ONCBeigene$267.70+0.1%1.1438 of 5 stars3.00$310.00 15.8%3Gap Up3.03%FUTUFutu$101.14-2.4%3.7047 of 5 stars2.80$121.20 19.8%5Gap Up2.99%IDCCInterDigital$205.78-2.0%1.5618 of 5 stars2.00$120.00 -41.7%3Positive News2.97%PLMRPalomar$137.22+0.3%2.0499 of 5 stars2.57$127.83 -6.8%7Positive News2.97%WGSGeneDx$88.49-4.0%2.2797 of 5 stars2.50$72.33 -18.3%6Insider TradeGap Down2.88%GHGuardant Health$42.34-1.9%4.2684 of 5 stars3.00$48.95 15.6%20News CoveragePositive NewsGap Down2.81%ARISAris Water Solutions$32.16+1.2%2.0177 of 5 stars2.33$27.00 -16.0%6Positive News2.05%TWTradeweb Markets$148.37+1.1%3.7755 of 5 stars2.85$138.50 -6.7%13Positive News2.03%MELIMercadoLibre$1,942.50-5.2%4.5317 of 5 stars3.06$2,402.81 23.7%17Positive NewsGap Down1.99%RYANRyan Specialty$74.16+1.7%1.9542 of 5 stars2.38$75.27 1.5%13Positive News1.97%BROBrown & Brown$123.36+0.3%3.8766 of 5 stars2.42$112.67 -8.7%12Short Interest ↑News CoveragePositive News1.97%SKWDSkyward Specialty Insurance Group$53.03+0.8%4.1898 of 5 stars2.82$56.25 6.1%11Short Interest ↓Positive News1.95%RGLDRoyal Gold$163.03+0.5%3.9724 of 5 stars2.38$168.86 3.6%8News CoveragePositive News1.95%AJGArthur J. Gallagher & Co.$343.33+0.8%4.5928 of 5 stars2.27$313.20 -8.8%15Short Interest ↓Positive News1.95%DASHDoorDash$177.77-2.7%3.3423 of 5 stars2.71$207.21 16.6%35Analyst ForecastShort Interest ↑Gap Down1.92%EXELExelixis$36.44-0.7%4.5283 of 5 stars2.50$37.59 3.2%20Upcoming EarningsAnalyst RevisionPositive News1.77%LILi Auto$25.13-1.5%3.8874 of 5 stars2.33$35.73 42.2%91.06%BZKanzhun$19.08-2.0%2.8081 of 5 stars2.56$21.71 13.8%9Positive News1.05%PDDPDD$118.63-1.5%4.7939 of 5 stars2.71$169.91 43.2%14Positive News1.02%HESMHess Midstream$42.17-0.8%2.738 of 5 stars2.60$43.00 2.0%5Short Interest ↑1.01%TRVTravelers Companies$262.89+0.4%4.638 of 5 stars2.13$260.00 -1.1%23Positive News0.99%ALKSAlkermes$32.72-1.5%4.5956 of 5 stars2.69$39.38 20.4%13Positive News0.99%OPCHOption Care Health$34.88+0.4%3.9093 of 5 stars2.75$33.00 -5.4%8Positive News0.97%ODDOddity Tech$42.84-0.2%0.6622 of 5 stars2.63$53.00 23.7%8Positive News0.95%AONAON$396.73+0.6%3.6561 of 5 stars2.29$386.21 -2.7%14Positive News0.94%VSECVSE$117.48+0.7%1.8026 of 5 stars3.00$118.67 1.0%6Gap Down0.50%HEIHEICO$265.73-0.1%1.4809 of 5 stars2.67$271.40 2.1%120.50%CORCencora$277.00+0.7%3.9497 of 5 stars2.80$280.20 1.2%10News CoveragePositive News0.50%WRBW. R. Berkley$70.65-0.9%4.3533 of 5 stars2.38$64.36 -8.9%13News CoveragePositive News0.50%AEEAmeren$100.20+0.5%4.0737 of 5 stars2.64$96.70 -3.5%11Analyst Revision0.49%LNTHLantheus$97.26+1.1%4.2746 of 5 stars3.00$129.43 33.1%70.49%AZNAstraZeneca$72.64-1.6%2.8251 of 5 stars3.10$89.75 23.6%10Positive News0.49%VEEVVeeva Systems$229.74-1.9%4.454 of 5 stars2.52$256.52 11.7%25Analyst RevisionPositive News0.48%FRFirst Industrial Realty Trust$53.79+1.1%3.7458 of 5 stars2.43$58.38 8.5%14Short Interest ↑News CoveragePositive News This page (NYSEARCA:FFTY) was last updated on 3/31/2025 by MarketBeat.com Staff From Our PartnersA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Great Society Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Innovator IBD 50 ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Innovator IBD 50 ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
